In a press conference at Albany Medical Center on Monday, Senator Chuck Schumer deplored what he called a "dramatic cut to upstate New York hospitals," which he claimed would force layoffs and threaten "critical care services such as cancer treatment, addiction treatment and prescription drug access." The senator's depiction of a complex policy change was alarmist and misleading.
The Trump administration’s move this week to suspend the Affordable Care Act’s “risk adjustment” program leaves more than $300 million in payments to and from New York’s health plans in limbo and further destabilizes the state’s ACA market.
From 2014 to 2016, New York’s Medicaid program saw a surge in drug spending that Governor Andrew Cuomo blamed on “abusive” behavior by drug manufacturers. A new Empire Center issue brief shows that, after accounting for rebates, the surge was smaller than Cuomo described, and that it was mostly driven by enrollment growth. Overall, the report finds that price increases accounted for about one-fifth of the spending surge, while enrollment accounted for four-fifths.
If Governor Cuomo succeeds in imposing a tax on prescription opioids, state government would largely be taxing itself.
Federal officials have reportedly confirmed that they are cutting off a major portion of funding for New York’s Essential Plan, opening a roughly $1 billion hole in the state budget and raising new doubts about the future of a rapidly growing health insurance option for the working poor.
A technical change in how Medicare compensates hospitals for treating the poor and uninsured has drawn a heated response from Governor Andrew Cuomo that demands clarification.
New York would pay a price for running a high-cost Medicaid program if the Senate GOP health plan becomes law.
New York is planning to demur from some of the Trump administration’s rule changes for Obamacare, including its much shorter enrollment window.